Antitumor agents

Details Antitumor agents Antitumor agents

2007-07-10

2007-07-10

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S153000

Reexamination Certificate

active

11009457

ABSTRACT:
The invention provides compounds of formula I:wherein Y is F, Cl, Br, methyl or methoxy; and pharmaceutically acceptable salts thereof. The compounds are effective antitumor agents. The invention also provides pharmaceutical compositions comprising a compound of formula I or a salt thereof, intermediates useful for preparing a compound of formula I, and therapeutic methods comprising administering a compound of formula I or a salt thereof to a mammal in need thereof.

REFERENCES:
patent: 4629493 (1986-12-01), Ura et al.
patent: 5250690 (1993-10-01), Turner et al.
patent: 5364831 (1994-11-01), Ura et al.
patent: 6197728 (2001-03-01), Ura et al.
patent: 6867219 (2005-03-01), Horwitz et al.
Balasubramanian, B. N., et al., “Chapter 15: Recent Developments in Cancer Cytotoxics”,In: Annual Reports in Medicinal Chemistry, Academic Press, San Diego, CA, (1998), 151-159.
Corbett, T., et al., “Preclinical Antitumor Efficacy of Analogs of XK469:sodium-(2-[4-(7-chloro-2-quinoxalinyloxy) phenoxy]propionate”,Investigational New Drugs, 16(2), (1998), 129-139.
Corbett, T., et al., “Tumor Models and the Discovery and Secondary Evaluation of Solid Tumor Active Agents”,International Journal of Pharmacognosy, 33 (Supplement), (1995), 102-122.
Draetta, G., et al., “Chapter 25: Cell Cycle Control and Cancer”,In: Annual Reports in Medicinal Chemistry, 31, Academic Press, Inc., San Diego, (1996), 241-246.
Hazeldine, S. T., “Design, Synthesis, and Biological Evaluation of Analogues of the Antitumor Agent, 2-{4-[(7-Chloro-2-quinoxalinyl)oxy]phenoxy}propionic Acid (XK469)”,Journal of Medicinal Chemistry, 44(11), (2001), 1758-1776.
Hazeldine, S. T., et al., II. Synthesis and Biological Evaluation of Some Bioisoteres and Congeners of the Antitumor Agent, 2-{4-[(7-Chloro-2-quinoxalinyl)oxy]phenoxy}propionic Acid (XK469),Journal of Medicinal Chemistry, 45, (2002), 3130-3137.
Lorusso, P. M., et al., “Preclinical Antitumor Activity of XK469 (NSC 656889)”,Investigational New Drugs, 16(4), (1998-1999), 287-296.
Nissan Chemical Industries, Ltd., Abstract No. 24844r, Quinoline Derivatives,Chemical Abstracts, 95, (1981), p. 678.
Polin, L., et al., “Preclinical Efficacy Evaluations of XK-469: Dose Schedule, Route and Cross-Resistance Behavior in Tumor Bearing Mice”,Investigational New Drugs, 20(1), (2002), 13-22.
Salmon, S. E., et al., “Principles of Cancer Therapy”,Oncology, XIV, (1999), 1036-1049.

Affiliated with

Also associated with

Rating

Antitumor agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antitumor agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3814443